IonQ (IONQ) Stock Forecast 2026–2030: Long-Term Outlook

IonQ trades at $31.27 with a market capitalization of $12.8 billion as of late October 2026, putting it at the center of the commercial race for quantum computing. This article walks through where the business stands today, what Wall Street analysts predict over the next 12 months, and how different growth trajectories could shape the stock through 2030.

Before looking at any numbers, it helps to remember that long-range share projections are hypothetical scenarios, not guaranteed outcomes. They show the mathematical relationship between revenue growth, valuation multiples, and dilution, helping you understand what IonQ must achieve to justify its price.

Share price	$31.27 (Oct 22, 2026)
Market value	about $12.8 billion
52-week range	$25.89 – $73.65
Revenue, last 12 months	about $246.5 million
Revenue growth, last fiscal year	202%
Net income, last 12 months	a loss of about $1.4 billion
Price-to-sales	about 51.9×
Price-to-earnings	n/a (not profitable)
Analyst 12-month target	average $67.73 (range $43 – $100); 10 buy, 1 hold, 0 sell

Market data from Nasdaq as of October 24, 2026. Check current figures before making any decision.

The table above summarizes where the company’s valuation stands right now. Even after pulling back from a 52-week peak of $73.65, IonQ trades at a price-to-sales ratio near 52, which prices in enormous operational expansion over the coming years.

What IonQ does

IonQ operates as a quantum computing platform and foundry, delivering hardware, networking, sensing, and security solutions. Unlike traditional semiconductor firms that rely on silicon transistors, IonQ designs trapped-ion quantum computers. Its newest generation system is known as the Superion, built to scale processing capabilities beyond earlier generations.

The company earns revenue through cloud access contracts, hardware sales, and commercial research partnerships. Customers can access IonQ systems via major cloud services like Amazon Web Services, as well as direct enterprise collaborations. Its partner roster includes industry giants such as AstraZeneca and NVIDIA, who use the hardware to speed up complex calculations in drug discovery, materials science, financial modeling, logistics, defense, and cybersecurity.

A central selling point for IonQ is technical fidelity. In 2025, the company achieved a 99.99% two-qubit gate fidelity, setting a world record in quantum computing benchmark testing. That high level of accuracy is necessary for commercial clients to achieve a genuine computing advantage over classical supercomputers.

Where the business stands today

IonQ has expanded its top-line revenue at a rapid pace over the past few years. Total annual revenue grew from $22.0 million in 2023 to $43.1 million in 2024, and then jumped 201.9% to reach $130.0 million in fiscal year 2025. Over the last four reported quarters ending June 30, 2026, trailing revenue reached $246.5 million.

Recent quarterly numbers show continued top-line momentum:

• Quarter ending September 30, 2025: $39.87 million
• Quarter ending December 31, 2025: $61.89 million
• Quarter ending March 31, 2026: $64.67 million
• Quarter ending June 30, 2026: $80.05 million

Despite that sales growth, IonQ remains deeply unprofitable, mirroring capital-heavy tech models like those explored in our SoundHound AI stock forecast or early-stage hardware plays like Rocket Lab. For fiscal year 2024, IonQ reported a net loss of $331.6 million, which widened to $510.4 million in fiscal year 2025. Across the last four quarters, the net loss reached $1.4 billion.

Earnings per share (EPS) results have also been volatile relative to Wall Street targets. In the quarter ending September 2025, IonQ missed expectations sharply, posting an EPS of -$3.58 against an estimated -$0.44. The company surprised positively in the December 2025 quarter with an EPS of $1.93 versus an expected -$0.48. However, 2026 returned to misses: the March quarter showed an EPS of -$0.73 (against a -$0.55 consensus), and the June quarter reported an EPS of -$0.72 (against a -$0.59 consensus). Consensus analyst forecasts project IonQ’s annual EPS to stay negative through the next several years: -$2.96 in 2026, -$3.06 in 2027, and -$3.08 in 2028.

What is the 12-month IonQ price target?

Wall Street sentiment remains optimistic in the near term. According to Nasdaq consensus data covering 11 analysts, 10 rate the stock a Buy, 1 rates it a Hold, and none recommend selling.

The average 12-month IonQ price target sits at $67.73, which represents upside of about 116.6% from the current price of $31.27. The most conservative analyst target is $43.00, while the street-high target reaches $100.00.

For the stock to push toward that $67.73 consensus target over the next year, IonQ would likely need to maintain its quarterly revenue climb, narrow its unexpected bottom-line losses, and announce expanded enterprise deployments for its Superion system. However, investors should keep in mind that 12-month analyst targets focus on near-term market sentiment, whereas multi-year returns depend on how valuation multiples adjust as sales mature.

IonQ stock forecast for 2030: three long-term scenarios

Evaluating an IonQ stock prediction through 2030 requires projecting both revenue expansion and multiple compression. IonQ currently trades at a price-to-sales multiple of roughly 52. Young, fast-growing companies rarely keep such high multiples as their revenue grows into the billions.

The scenarios below start from the trailing $246.5 million in revenue, compound sales through 2030 with growth rates that gradually moderate, apply normalized price-to-sales multiples, and factor in share dilution from ongoing stock issuance.

Scenario	Revenue growth per year	2030 revenue	Price-to-sales	Shares	Implied share price
Bear	50% slowing to 5%	$628.9 million	5.0×	460 million	about $6.83 (-78%)
Base	100% slowing to 15%	$1.4 billion	10.0×	434 million	about $32.14 (+3%)
Bull	182% slowing to 25%	$3.5 billion	18.0×	417 million	about $152.26 (+387%)

At IonQ’s current price of $31.27, the market is already pricing in massive growth. Specifically, at a base-case multiple of 10 times sales and an expected diluted share count of 434 million shares, IonQ must generate roughly $1.4 billion in annual revenue by 2030 just to trade near today’s share price.

Bear case

In the bear case, commercial adoption of quantum computing takes longer than expected, or competitors edge into IonQ’s client base. Revenue growth decelerates from 50% down to 5% annually, averaging about 26% per year. IonQ reaches $628.9 million in revenue in 2030. As growth normalizes, the valuation multiple drops to 5 times sales. With share dilution bringing the count to 460 million, the implied share price falls to $6.83, a 78% drop from current levels.

Base case

In the base case, enterprise demand for the Superion architecture expands steadily across biotech, finance, and logistics. Sales growth starts at 100% and slows to 15% annually by 2030, averaging about 54% per year. Revenue lands at $1.4 billion. Assuming the market awards IonQ a premium price-to-sales multiple of 10, and share dilution rises to 434 million, the stock trades at roughly $32.14, essentially flat with today’s price.

Bull case

In the bull case, IonQ establishes an industry standard in quantum computing and networking, retaining world-record gate fidelity and converting major pilots with partners like AWS and NVIDIA into massive recurring contracts. Sales growth begins at 182% and cools to 25%, averaging roughly 95% per year. Revenue surges to $3.5 billion in 2030. At an 18 times sales multiple and 417 million shares, the stock reaches $152.26, gaining roughly 387%.

The main takeaway from these cases is clear: because IonQ already trades at 52 times trailing sales, the company must deliver around 54% annualized growth for four years just for the stock to hold its current ground once the multiple compresses to 10.

Risks to weigh

Before making any investment decisions, consider the major headwinds facing the business:

• Heavy net losses: IonQ lost $1.4 billion over the last four reported quarters, and analyst consensus expects losses per share to remain around -$3.00 through at least 2028.
• Dilution risk: Funding ongoing cash burn without debt will likely require issuing additional equity, which expands the share count and reduces existing shareholders’ slice of future earnings.
• Valuation sensitivity: Trading at more than 50 times sales leaves little margin for operational error. Any slowdown in quarterly sales could trigger sharp multiple contractions, similar to high-valuation tech swings seen in our Super Micro Computer stock forecast.
• Commercial timing: Broad commercial adoption of quantum algorithms remains in early stages. If corporate clients take longer to convert experimental budgets into recurring software and foundry fees, top-line estimates could fall short.

What to watch next

If you hold or are researching IonQ, track whether quarterly revenue continues to expand above the $80 million mark established in mid-2026. Watch the bottom line for signs that net losses are stabilizing rather than expanding. Finally, monitor customer additions for the Superion platform, as long-term returns will rely on high-margin commercial contracts replacing early research pilots.

FAQ

Market data and financials: Nasdaq. Scenario math: investing20.

This article is for information only and is not investment advice. Do your own research before investing.